1078 related articles for article (PubMed ID: 18511133)
41. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
42. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
[TBL] [Abstract][Full Text] [Related]
43. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
44. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model.
Ren XG; Xue F; Zhu YM; Tong GZ; Wang YH; Feng JK; Shi HF; Gao YR
Biotechnol Lett; 2009 Aug; 31(8):1159-65. PubMed ID: 19343503
[TBL] [Abstract][Full Text] [Related]
45. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
46. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
[TBL] [Abstract][Full Text] [Related]
47. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide.
Wang JL; Liu MQ; Han J; Chen WZ; Cong W; Cheng G; Gao YH; Lu YG; Chen JL; Zuo XP; Yan WY; Zheng ZX
Vet Microbiol; 2007 Dec; 125(3-4):224-31. PubMed ID: 17656048
[TBL] [Abstract][Full Text] [Related]
48. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Moraes MP; Chinsangaram J; Brum MC; Grubman MJ
Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155
[TBL] [Abstract][Full Text] [Related]
49. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.
Wang X; Jiang W; Jiang P; Li Y; Feng Z; Xu J
Vaccine; 2006 Apr; 24(16):3374-80. PubMed ID: 16524646
[TBL] [Abstract][Full Text] [Related]
50. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
[TBL] [Abstract][Full Text] [Related]
51. Engineering better vaccines for foot-and-mouth disease.
Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
[TBL] [Abstract][Full Text] [Related]
53. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
54. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
55. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
[TBL] [Abstract][Full Text] [Related]
56. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.
Cao J; Wang X; Du Y; Li Y; Wang X; Jiang P
Vaccine; 2010 Nov; 28(47):7514-22. PubMed ID: 20851084
[TBL] [Abstract][Full Text] [Related]
57. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
58. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
59. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
[TBL] [Abstract][Full Text] [Related]
60. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
